Global Paediatric Influenza Prevention Market Growth 2026-2032
The global Paediatric Influenza Prevention market size is predicted to grow from US$ 1742 million in 2025 to US$ 2288 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
Pediatric influenza prevention focuses on strategies to protect children from the flu. This includes annual flu vaccination, which is highly recommended for children over six months old, as well as practices like regular handwashing, covering coughs, and avoiding close contact with infected individuals. Because young children are more vulnerable to severe flu complications, preventive measures are essential in minimizing their risk of infection and helping to prevent flu spread within families and communities.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Paediatric Influenza Prevention Industry Forecast” looks at past sales and reviews total world Paediatric Influenza Prevention sales in 2025, providing a comprehensive analysis by region and market sector of projected Paediatric Influenza Prevention sales for 2026 through 2032. With Paediatric Influenza Prevention sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paediatric Influenza Prevention industry.
This Insight Report provides a comprehensive analysis of the global Paediatric Influenza Prevention landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paediatric Influenza Prevention portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paediatric Influenza Prevention market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paediatric Influenza Prevention and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paediatric Influenza Prevention.
This report presents a comprehensive overview, market shares, and growth opportunities of Paediatric Influenza Prevention market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Paediatric Influenza Prevention market?
What factors are driving Paediatric Influenza Prevention market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paediatric Influenza Prevention market opportunities vary by end market size?
How does Paediatric Influenza Prevention break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Pediatric influenza prevention focuses on strategies to protect children from the flu. This includes annual flu vaccination, which is highly recommended for children over six months old, as well as practices like regular handwashing, covering coughs, and avoiding close contact with infected individuals. Because young children are more vulnerable to severe flu complications, preventive measures are essential in minimizing their risk of infection and helping to prevent flu spread within families and communities.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Paediatric Influenza Prevention Industry Forecast” looks at past sales and reviews total world Paediatric Influenza Prevention sales in 2025, providing a comprehensive analysis by region and market sector of projected Paediatric Influenza Prevention sales for 2026 through 2032. With Paediatric Influenza Prevention sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paediatric Influenza Prevention industry.
This Insight Report provides a comprehensive analysis of the global Paediatric Influenza Prevention landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paediatric Influenza Prevention portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paediatric Influenza Prevention market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paediatric Influenza Prevention and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paediatric Influenza Prevention.
This report presents a comprehensive overview, market shares, and growth opportunities of Paediatric Influenza Prevention market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Nasal Spray
- Injection
- Public
- Private
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- Hulan Bio
- AstraZeneca
- CCBIO
- Sinovac
- BCHT
- Jiangsu GDK
- KM Biologics
What is the 10-year outlook for the global Paediatric Influenza Prevention market?
What factors are driving Paediatric Influenza Prevention market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paediatric Influenza Prevention market opportunities vary by end market size?
How does Paediatric Influenza Prevention break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paediatric Influenza Prevention Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Paediatric Influenza Prevention by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Paediatric Influenza Prevention by Country/Region, 2021, 2025 & 2032
2.2 Paediatric Influenza Prevention Segment by Type
2.2.1 Nasal Spray
2.2.2 Injection
2.2.3 Paediatric Influenza Prevention Sales by Type
2.2.3.1 Global Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
2.2.3.2 Global Paediatric Influenza Prevention Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Paediatric Influenza Prevention Sale Price by Type (2021-2026)
2.3 Paediatric Influenza Prevention Segment by Application
2.3.1 Public
2.3.2 Private
2.3.3 Paediatric Influenza Prevention Sales by Application
2.3.3.1 Global Paediatric Influenza Prevention Sale Market Share by Application (2021-2026)
2.3.3.2 Global Paediatric Influenza Prevention Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Paediatric Influenza Prevention Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Paediatric Influenza Prevention Breakdown Data by Company
3.1.1 Global Paediatric Influenza Prevention Annual Sales by Company (2021-2026)
3.1.2 Global Paediatric Influenza Prevention Sales Market Share by Company (2021-2026)
3.2 Global Paediatric Influenza Prevention Annual Revenue by Company (2021-2026)
3.2.1 Global Paediatric Influenza Prevention Revenue by Company (2021-2026)
3.2.2 Global Paediatric Influenza Prevention Revenue Market Share by Company (2021-2026)
3.3 Global Paediatric Influenza Prevention Sale Price by Company
3.4 Key Manufacturers Paediatric Influenza Prevention Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paediatric Influenza Prevention Product Location Distribution
3.4.2 Players Paediatric Influenza Prevention Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PAEDIATRIC INFLUENZA PREVENTION BY GEOGRAPHIC REGION
4.1 World Historic Paediatric Influenza Prevention Market Size by Geographic Region (2021-2026)
4.1.1 Global Paediatric Influenza Prevention Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Paediatric Influenza Prevention Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Paediatric Influenza Prevention Market Size by Country/Region (2021-2026)
4.2.1 Global Paediatric Influenza Prevention Annual Sales by Country/Region (2021-2026)
4.2.2 Global Paediatric Influenza Prevention Annual Revenue by Country/Region (2021-2026)
4.3 Americas Paediatric Influenza Prevention Sales Growth
4.4 APAC Paediatric Influenza Prevention Sales Growth
4.5 Europe Paediatric Influenza Prevention Sales Growth
4.6 Middle East & Africa Paediatric Influenza Prevention Sales Growth
5 AMERICAS
5.1 Americas Paediatric Influenza Prevention Sales by Country
5.1.1 Americas Paediatric Influenza Prevention Sales by Country (2021-2026)
5.1.2 Americas Paediatric Influenza Prevention Revenue by Country (2021-2026)
5.2 Americas Paediatric Influenza Prevention Sales by Type (2021-2026)
5.3 Americas Paediatric Influenza Prevention Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paediatric Influenza Prevention Sales by Region
6.1.1 APAC Paediatric Influenza Prevention Sales by Region (2021-2026)
6.1.2 APAC Paediatric Influenza Prevention Revenue by Region (2021-2026)
6.2 APAC Paediatric Influenza Prevention Sales by Type (2021-2026)
6.3 APAC Paediatric Influenza Prevention Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paediatric Influenza Prevention by Country
7.1.1 Europe Paediatric Influenza Prevention Sales by Country (2021-2026)
7.1.2 Europe Paediatric Influenza Prevention Revenue by Country (2021-2026)
7.2 Europe Paediatric Influenza Prevention Sales by Type (2021-2026)
7.3 Europe Paediatric Influenza Prevention Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paediatric Influenza Prevention by Country
8.1.1 Middle East & Africa Paediatric Influenza Prevention Sales by Country (2021-2026)
8.1.2 Middle East & Africa Paediatric Influenza Prevention Revenue by Country (2021-2026)
8.2 Middle East & Africa Paediatric Influenza Prevention Sales by Type (2021-2026)
8.3 Middle East & Africa Paediatric Influenza Prevention Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paediatric Influenza Prevention
10.3 Manufacturing Process Analysis of Paediatric Influenza Prevention
10.4 Industry Chain Structure of Paediatric Influenza Prevention
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paediatric Influenza Prevention Distributors
11.3 Paediatric Influenza Prevention Customer
12 WORLD FORECAST REVIEW FOR PAEDIATRIC INFLUENZA PREVENTION BY GEOGRAPHIC REGION
12.1 Global Paediatric Influenza Prevention Market Size Forecast by Region
12.1.1 Global Paediatric Influenza Prevention Forecast by Region (2027-2032)
12.1.2 Global Paediatric Influenza Prevention Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Paediatric Influenza Prevention Forecast by Type (2027-2032)
12.7 Global Paediatric Influenza Prevention Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Paediatric Influenza Prevention Product Portfolios and Specifications
13.1.3 Sanofi Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Paediatric Influenza Prevention Product Portfolios and Specifications
13.2.3 CSL Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Paediatric Influenza Prevention Product Portfolios and Specifications
13.3.3 GSK Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Paediatric Influenza Prevention Product Portfolios and Specifications
13.4.3 Viatris Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 Hulan Bio
13.5.1 Hulan Bio Company Information
13.5.2 Hulan Bio Paediatric Influenza Prevention Product Portfolios and Specifications
13.5.3 Hulan Bio Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hulan Bio Main Business Overview
13.5.5 Hulan Bio Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Paediatric Influenza Prevention Product Portfolios and Specifications
13.6.3 AstraZeneca Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 CCBIO
13.7.1 CCBIO Company Information
13.7.2 CCBIO Paediatric Influenza Prevention Product Portfolios and Specifications
13.7.3 CCBIO Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CCBIO Main Business Overview
13.7.5 CCBIO Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Paediatric Influenza Prevention Product Portfolios and Specifications
13.8.3 Sinovac Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Paediatric Influenza Prevention Product Portfolios and Specifications
13.9.3 BCHT Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Paediatric Influenza Prevention Product Portfolios and Specifications
13.10.3 Jiangsu GDK Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Paediatric Influenza Prevention Product Portfolios and Specifications
13.11.3 KM Biologics Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paediatric Influenza Prevention Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Paediatric Influenza Prevention by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Paediatric Influenza Prevention by Country/Region, 2021, 2025 & 2032
2.2 Paediatric Influenza Prevention Segment by Type
2.2.1 Nasal Spray
2.2.2 Injection
2.2.3 Paediatric Influenza Prevention Sales by Type
2.2.3.1 Global Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
2.2.3.2 Global Paediatric Influenza Prevention Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Paediatric Influenza Prevention Sale Price by Type (2021-2026)
2.3 Paediatric Influenza Prevention Segment by Application
2.3.1 Public
2.3.2 Private
2.3.3 Paediatric Influenza Prevention Sales by Application
2.3.3.1 Global Paediatric Influenza Prevention Sale Market Share by Application (2021-2026)
2.3.3.2 Global Paediatric Influenza Prevention Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Paediatric Influenza Prevention Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Paediatric Influenza Prevention Breakdown Data by Company
3.1.1 Global Paediatric Influenza Prevention Annual Sales by Company (2021-2026)
3.1.2 Global Paediatric Influenza Prevention Sales Market Share by Company (2021-2026)
3.2 Global Paediatric Influenza Prevention Annual Revenue by Company (2021-2026)
3.2.1 Global Paediatric Influenza Prevention Revenue by Company (2021-2026)
3.2.2 Global Paediatric Influenza Prevention Revenue Market Share by Company (2021-2026)
3.3 Global Paediatric Influenza Prevention Sale Price by Company
3.4 Key Manufacturers Paediatric Influenza Prevention Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paediatric Influenza Prevention Product Location Distribution
3.4.2 Players Paediatric Influenza Prevention Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PAEDIATRIC INFLUENZA PREVENTION BY GEOGRAPHIC REGION
4.1 World Historic Paediatric Influenza Prevention Market Size by Geographic Region (2021-2026)
4.1.1 Global Paediatric Influenza Prevention Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Paediatric Influenza Prevention Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Paediatric Influenza Prevention Market Size by Country/Region (2021-2026)
4.2.1 Global Paediatric Influenza Prevention Annual Sales by Country/Region (2021-2026)
4.2.2 Global Paediatric Influenza Prevention Annual Revenue by Country/Region (2021-2026)
4.3 Americas Paediatric Influenza Prevention Sales Growth
4.4 APAC Paediatric Influenza Prevention Sales Growth
4.5 Europe Paediatric Influenza Prevention Sales Growth
4.6 Middle East & Africa Paediatric Influenza Prevention Sales Growth
5 AMERICAS
5.1 Americas Paediatric Influenza Prevention Sales by Country
5.1.1 Americas Paediatric Influenza Prevention Sales by Country (2021-2026)
5.1.2 Americas Paediatric Influenza Prevention Revenue by Country (2021-2026)
5.2 Americas Paediatric Influenza Prevention Sales by Type (2021-2026)
5.3 Americas Paediatric Influenza Prevention Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paediatric Influenza Prevention Sales by Region
6.1.1 APAC Paediatric Influenza Prevention Sales by Region (2021-2026)
6.1.2 APAC Paediatric Influenza Prevention Revenue by Region (2021-2026)
6.2 APAC Paediatric Influenza Prevention Sales by Type (2021-2026)
6.3 APAC Paediatric Influenza Prevention Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paediatric Influenza Prevention by Country
7.1.1 Europe Paediatric Influenza Prevention Sales by Country (2021-2026)
7.1.2 Europe Paediatric Influenza Prevention Revenue by Country (2021-2026)
7.2 Europe Paediatric Influenza Prevention Sales by Type (2021-2026)
7.3 Europe Paediatric Influenza Prevention Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paediatric Influenza Prevention by Country
8.1.1 Middle East & Africa Paediatric Influenza Prevention Sales by Country (2021-2026)
8.1.2 Middle East & Africa Paediatric Influenza Prevention Revenue by Country (2021-2026)
8.2 Middle East & Africa Paediatric Influenza Prevention Sales by Type (2021-2026)
8.3 Middle East & Africa Paediatric Influenza Prevention Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paediatric Influenza Prevention
10.3 Manufacturing Process Analysis of Paediatric Influenza Prevention
10.4 Industry Chain Structure of Paediatric Influenza Prevention
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paediatric Influenza Prevention Distributors
11.3 Paediatric Influenza Prevention Customer
12 WORLD FORECAST REVIEW FOR PAEDIATRIC INFLUENZA PREVENTION BY GEOGRAPHIC REGION
12.1 Global Paediatric Influenza Prevention Market Size Forecast by Region
12.1.1 Global Paediatric Influenza Prevention Forecast by Region (2027-2032)
12.1.2 Global Paediatric Influenza Prevention Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Paediatric Influenza Prevention Forecast by Type (2027-2032)
12.7 Global Paediatric Influenza Prevention Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Paediatric Influenza Prevention Product Portfolios and Specifications
13.1.3 Sanofi Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Paediatric Influenza Prevention Product Portfolios and Specifications
13.2.3 CSL Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Paediatric Influenza Prevention Product Portfolios and Specifications
13.3.3 GSK Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Paediatric Influenza Prevention Product Portfolios and Specifications
13.4.3 Viatris Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 Hulan Bio
13.5.1 Hulan Bio Company Information
13.5.2 Hulan Bio Paediatric Influenza Prevention Product Portfolios and Specifications
13.5.3 Hulan Bio Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Hulan Bio Main Business Overview
13.5.5 Hulan Bio Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Paediatric Influenza Prevention Product Portfolios and Specifications
13.6.3 AstraZeneca Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 CCBIO
13.7.1 CCBIO Company Information
13.7.2 CCBIO Paediatric Influenza Prevention Product Portfolios and Specifications
13.7.3 CCBIO Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CCBIO Main Business Overview
13.7.5 CCBIO Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Paediatric Influenza Prevention Product Portfolios and Specifications
13.8.3 Sinovac Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 BCHT
13.9.1 BCHT Company Information
13.9.2 BCHT Paediatric Influenza Prevention Product Portfolios and Specifications
13.9.3 BCHT Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 BCHT Main Business Overview
13.9.5 BCHT Latest Developments
13.10 Jiangsu GDK
13.10.1 Jiangsu GDK Company Information
13.10.2 Jiangsu GDK Paediatric Influenza Prevention Product Portfolios and Specifications
13.10.3 Jiangsu GDK Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangsu GDK Main Business Overview
13.10.5 Jiangsu GDK Latest Developments
13.11 KM Biologics
13.11.1 KM Biologics Company Information
13.11.2 KM Biologics Paediatric Influenza Prevention Product Portfolios and Specifications
13.11.3 KM Biologics Paediatric Influenza Prevention Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 KM Biologics Main Business Overview
13.11.5 KM Biologics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Paediatric Influenza Prevention Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Paediatric Influenza Prevention Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nasal Spray
Table 4. Major Players of Injection
Table 5. Global Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 6. Global Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Table 7. Global Paediatric Influenza Prevention Revenue by Type (2021-2026) & ($ million)
Table 8. Global Paediatric Influenza Prevention Revenue Market Share by Type (2021-2026)
Table 9. Global Paediatric Influenza Prevention Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Paediatric Influenza Prevention Sale by Application (2021-2026) & (K Units)
Table 11. Global Paediatric Influenza Prevention Sale Market Share by Application (2021-2026)
Table 12. Global Paediatric Influenza Prevention Revenue by Application (2021-2026) & ($ million)
Table 13. Global Paediatric Influenza Prevention Revenue Market Share by Application (2021-2026)
Table 14. Global Paediatric Influenza Prevention Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Paediatric Influenza Prevention Sales by Company (2021-2026) & (K Units)
Table 16. Global Paediatric Influenza Prevention Sales Market Share by Company (2021-2026)
Table 17. Global Paediatric Influenza Prevention Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Paediatric Influenza Prevention Revenue Market Share by Company (2021-2026)
Table 19. Global Paediatric Influenza Prevention Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Paediatric Influenza Prevention Producing Area Distribution and Sales Area
Table 21. Players Paediatric Influenza Prevention Products Offered
Table 22. Paediatric Influenza Prevention Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Paediatric Influenza Prevention Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Paediatric Influenza Prevention Sales Market Share Geographic Region (2021-2026)
Table 27. Global Paediatric Influenza Prevention Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Paediatric Influenza Prevention Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Paediatric Influenza Prevention Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Paediatric Influenza Prevention Sales Market Share by Country/Region (2021-2026)
Table 31. Global Paediatric Influenza Prevention Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Paediatric Influenza Prevention Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units)
Table 34. Americas Paediatric Influenza Prevention Sales Market Share by Country (2021-2026)
Table 35. Americas Paediatric Influenza Prevention Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 37. Americas Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 38. APAC Paediatric Influenza Prevention Sales by Region (2021-2026) & (K Units)
Table 39. APAC Paediatric Influenza Prevention Sales Market Share by Region (2021-2026)
Table 40. APAC Paediatric Influenza Prevention Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 42. APAC Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 43. Europe Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units)
Table 44. Europe Paediatric Influenza Prevention Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 46. Europe Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Paediatric Influenza Prevention Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Paediatric Influenza Prevention
Table 52. Key Market Challenges & Risks of Paediatric Influenza Prevention
Table 53. Key Industry Trends of Paediatric Influenza Prevention
Table 54. Paediatric Influenza Prevention Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Paediatric Influenza Prevention Distributors List
Table 57. Paediatric Influenza Prevention Customer List
Table 58. Global Paediatric Influenza Prevention Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Paediatric Influenza Prevention Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Paediatric Influenza Prevention Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Paediatric Influenza Prevention Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Paediatric Influenza Prevention Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Paediatric Influenza Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Paediatric Influenza Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Paediatric Influenza Prevention Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Paediatric Influenza Prevention Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Paediatric Influenza Prevention Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Paediatric Influenza Prevention Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Paediatric Influenza Prevention Product Portfolios and Specifications
Table 74. Sanofi Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Paediatric Influenza Prevention Product Portfolios and Specifications
Table 79. CSL Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Paediatric Influenza Prevention Product Portfolios and Specifications
Table 84. GSK Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Paediatric Influenza Prevention Product Portfolios and Specifications
Table 89. Viatris Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. Hulan Bio Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 93. Hulan Bio Paediatric Influenza Prevention Product Portfolios and Specifications
Table 94. Hulan Bio Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hulan Bio Main Business
Table 96. Hulan Bio Latest Developments
Table 97. AstraZeneca Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Paediatric Influenza Prevention Product Portfolios and Specifications
Table 99. AstraZeneca Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. CCBIO Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 103. CCBIO Paediatric Influenza Prevention Product Portfolios and Specifications
Table 104. CCBIO Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CCBIO Main Business
Table 106. CCBIO Latest Developments
Table 107. Sinovac Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Paediatric Influenza Prevention Product Portfolios and Specifications
Table 109. Sinovac Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Paediatric Influenza Prevention Product Portfolios and Specifications
Table 114. BCHT Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Paediatric Influenza Prevention Product Portfolios and Specifications
Table 119. Jiangsu GDK Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Paediatric Influenza Prevention Product Portfolios and Specifications
Table 124. KM Biologics Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
Table 1. Paediatric Influenza Prevention Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Paediatric Influenza Prevention Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Nasal Spray
Table 4. Major Players of Injection
Table 5. Global Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 6. Global Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Table 7. Global Paediatric Influenza Prevention Revenue by Type (2021-2026) & ($ million)
Table 8. Global Paediatric Influenza Prevention Revenue Market Share by Type (2021-2026)
Table 9. Global Paediatric Influenza Prevention Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Paediatric Influenza Prevention Sale by Application (2021-2026) & (K Units)
Table 11. Global Paediatric Influenza Prevention Sale Market Share by Application (2021-2026)
Table 12. Global Paediatric Influenza Prevention Revenue by Application (2021-2026) & ($ million)
Table 13. Global Paediatric Influenza Prevention Revenue Market Share by Application (2021-2026)
Table 14. Global Paediatric Influenza Prevention Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Paediatric Influenza Prevention Sales by Company (2021-2026) & (K Units)
Table 16. Global Paediatric Influenza Prevention Sales Market Share by Company (2021-2026)
Table 17. Global Paediatric Influenza Prevention Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Paediatric Influenza Prevention Revenue Market Share by Company (2021-2026)
Table 19. Global Paediatric Influenza Prevention Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Paediatric Influenza Prevention Producing Area Distribution and Sales Area
Table 21. Players Paediatric Influenza Prevention Products Offered
Table 22. Paediatric Influenza Prevention Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Paediatric Influenza Prevention Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Paediatric Influenza Prevention Sales Market Share Geographic Region (2021-2026)
Table 27. Global Paediatric Influenza Prevention Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Paediatric Influenza Prevention Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Paediatric Influenza Prevention Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Paediatric Influenza Prevention Sales Market Share by Country/Region (2021-2026)
Table 31. Global Paediatric Influenza Prevention Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Paediatric Influenza Prevention Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units)
Table 34. Americas Paediatric Influenza Prevention Sales Market Share by Country (2021-2026)
Table 35. Americas Paediatric Influenza Prevention Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 37. Americas Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 38. APAC Paediatric Influenza Prevention Sales by Region (2021-2026) & (K Units)
Table 39. APAC Paediatric Influenza Prevention Sales Market Share by Region (2021-2026)
Table 40. APAC Paediatric Influenza Prevention Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 42. APAC Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 43. Europe Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units)
Table 44. Europe Paediatric Influenza Prevention Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 46. Europe Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Paediatric Influenza Prevention Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Paediatric Influenza Prevention Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Paediatric Influenza Prevention Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Paediatric Influenza Prevention Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Paediatric Influenza Prevention
Table 52. Key Market Challenges & Risks of Paediatric Influenza Prevention
Table 53. Key Industry Trends of Paediatric Influenza Prevention
Table 54. Paediatric Influenza Prevention Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Paediatric Influenza Prevention Distributors List
Table 57. Paediatric Influenza Prevention Customer List
Table 58. Global Paediatric Influenza Prevention Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Paediatric Influenza Prevention Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Paediatric Influenza Prevention Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Paediatric Influenza Prevention Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Paediatric Influenza Prevention Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Paediatric Influenza Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Paediatric Influenza Prevention Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Paediatric Influenza Prevention Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Paediatric Influenza Prevention Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Paediatric Influenza Prevention Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Paediatric Influenza Prevention Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Paediatric Influenza Prevention Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi Paediatric Influenza Prevention Product Portfolios and Specifications
Table 74. Sanofi Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. CSL Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 78. CSL Paediatric Influenza Prevention Product Portfolios and Specifications
Table 79. CSL Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. CSL Main Business
Table 81. CSL Latest Developments
Table 82. GSK Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 83. GSK Paediatric Influenza Prevention Product Portfolios and Specifications
Table 84. GSK Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. GSK Main Business
Table 86. GSK Latest Developments
Table 87. Viatris Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 88. Viatris Paediatric Influenza Prevention Product Portfolios and Specifications
Table 89. Viatris Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Viatris Main Business
Table 91. Viatris Latest Developments
Table 92. Hulan Bio Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 93. Hulan Bio Paediatric Influenza Prevention Product Portfolios and Specifications
Table 94. Hulan Bio Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hulan Bio Main Business
Table 96. Hulan Bio Latest Developments
Table 97. AstraZeneca Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 98. AstraZeneca Paediatric Influenza Prevention Product Portfolios and Specifications
Table 99. AstraZeneca Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. AstraZeneca Main Business
Table 101. AstraZeneca Latest Developments
Table 102. CCBIO Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 103. CCBIO Paediatric Influenza Prevention Product Portfolios and Specifications
Table 104. CCBIO Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CCBIO Main Business
Table 106. CCBIO Latest Developments
Table 107. Sinovac Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 108. Sinovac Paediatric Influenza Prevention Product Portfolios and Specifications
Table 109. Sinovac Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Sinovac Main Business
Table 111. Sinovac Latest Developments
Table 112. BCHT Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 113. BCHT Paediatric Influenza Prevention Product Portfolios and Specifications
Table 114. BCHT Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. BCHT Main Business
Table 116. BCHT Latest Developments
Table 117. Jiangsu GDK Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 118. Jiangsu GDK Paediatric Influenza Prevention Product Portfolios and Specifications
Table 119. Jiangsu GDK Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Jiangsu GDK Main Business
Table 121. Jiangsu GDK Latest Developments
Table 122. KM Biologics Basic Information, Paediatric Influenza Prevention Manufacturing Base, Sales Area and Its Competitors
Table 123. KM Biologics Paediatric Influenza Prevention Product Portfolios and Specifications
Table 124. KM Biologics Paediatric Influenza Prevention Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. KM Biologics Main Business
Table 126. KM Biologics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Paediatric Influenza Prevention
Figure 2. Paediatric Influenza Prevention Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paediatric Influenza Prevention Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Paediatric Influenza Prevention Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Paediatric Influenza Prevention Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Paediatric Influenza Prevention Sales Market Share by Country/Region (2025)
Figure 10. Paediatric Influenza Prevention Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Nasal Spray
Figure 12. Product Picture of Injection
Figure 13. Global Paediatric Influenza Prevention Sales Market Share by Type in 2026
Figure 14. Global Paediatric Influenza Prevention Revenue Market Share by Type (2021-2026)
Figure 15. Paediatric Influenza Prevention Consumed in Public
Figure 16. Global Paediatric Influenza Prevention Market: Public (2021-2026) & (K Units)
Figure 17. Paediatric Influenza Prevention Consumed in Private
Figure 18. Global Paediatric Influenza Prevention Market: Private (2021-2026) & (K Units)
Figure 19. Global Paediatric Influenza Prevention Sale Market Share by Application (2025)
Figure 20. Global Paediatric Influenza Prevention Revenue Market Share by Application in 2026
Figure 21. Paediatric Influenza Prevention Sales by Company in 2026 (K Units)
Figure 22. Global Paediatric Influenza Prevention Sales Market Share by Company in 2026
Figure 23. Paediatric Influenza Prevention Revenue by Company in 2026 ($ millions)
Figure 24. Global Paediatric Influenza Prevention Revenue Market Share by Company in 2026
Figure 25. Global Paediatric Influenza Prevention Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Paediatric Influenza Prevention Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 28. Americas Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 29. APAC Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 30. APAC Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 31. Europe Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 32. Europe Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 35. Americas Paediatric Influenza Prevention Sales Market Share by Country in 2026
Figure 36. Americas Paediatric Influenza Prevention Revenue Market Share by Country (2021-2026)
Figure 37. Americas Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 38. Americas Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 39. United States Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Paediatric Influenza Prevention Sales Market Share by Region in 2026
Figure 44. APAC Paediatric Influenza Prevention Revenue Market Share by Region (2021-2026)
Figure 45. APAC Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 46. APAC Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 47. China Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 51. India Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Paediatric Influenza Prevention Sales Market Share by Country in 2026
Figure 55. Europe Paediatric Influenza Prevention Revenue Market Share by Country (2021-2026)
Figure 56. Europe Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 57. Europe Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 58. Germany Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 59. France Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Paediatric Influenza Prevention Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 66. Egypt Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Paediatric Influenza Prevention in 2026
Figure 72. Manufacturing Process Analysis of Paediatric Influenza Prevention
Figure 73. Industry Chain Structure of Paediatric Influenza Prevention
Figure 74. Channels of Distribution
Figure 75. Global Paediatric Influenza Prevention Sales Market Forecast by Region (2027-2032)
Figure 76. Global Paediatric Influenza Prevention Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Paediatric Influenza Prevention Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Paediatric Influenza Prevention Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Paediatric Influenza Prevention Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Paediatric Influenza Prevention Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Paediatric Influenza Prevention
Figure 2. Paediatric Influenza Prevention Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paediatric Influenza Prevention Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Paediatric Influenza Prevention Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Paediatric Influenza Prevention Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Paediatric Influenza Prevention Sales Market Share by Country/Region (2025)
Figure 10. Paediatric Influenza Prevention Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Nasal Spray
Figure 12. Product Picture of Injection
Figure 13. Global Paediatric Influenza Prevention Sales Market Share by Type in 2026
Figure 14. Global Paediatric Influenza Prevention Revenue Market Share by Type (2021-2026)
Figure 15. Paediatric Influenza Prevention Consumed in Public
Figure 16. Global Paediatric Influenza Prevention Market: Public (2021-2026) & (K Units)
Figure 17. Paediatric Influenza Prevention Consumed in Private
Figure 18. Global Paediatric Influenza Prevention Market: Private (2021-2026) & (K Units)
Figure 19. Global Paediatric Influenza Prevention Sale Market Share by Application (2025)
Figure 20. Global Paediatric Influenza Prevention Revenue Market Share by Application in 2026
Figure 21. Paediatric Influenza Prevention Sales by Company in 2026 (K Units)
Figure 22. Global Paediatric Influenza Prevention Sales Market Share by Company in 2026
Figure 23. Paediatric Influenza Prevention Revenue by Company in 2026 ($ millions)
Figure 24. Global Paediatric Influenza Prevention Revenue Market Share by Company in 2026
Figure 25. Global Paediatric Influenza Prevention Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Paediatric Influenza Prevention Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 28. Americas Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 29. APAC Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 30. APAC Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 31. Europe Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 32. Europe Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Paediatric Influenza Prevention Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Paediatric Influenza Prevention Revenue 2021-2026 ($ millions)
Figure 35. Americas Paediatric Influenza Prevention Sales Market Share by Country in 2026
Figure 36. Americas Paediatric Influenza Prevention Revenue Market Share by Country (2021-2026)
Figure 37. Americas Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 38. Americas Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 39. United States Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Paediatric Influenza Prevention Sales Market Share by Region in 2026
Figure 44. APAC Paediatric Influenza Prevention Revenue Market Share by Region (2021-2026)
Figure 45. APAC Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 46. APAC Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 47. China Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 51. India Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Paediatric Influenza Prevention Sales Market Share by Country in 2026
Figure 55. Europe Paediatric Influenza Prevention Revenue Market Share by Country (2021-2026)
Figure 56. Europe Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 57. Europe Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 58. Germany Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 59. France Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Paediatric Influenza Prevention Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Paediatric Influenza Prevention Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Paediatric Influenza Prevention Sales Market Share by Application (2021-2026)
Figure 66. Egypt Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Paediatric Influenza Prevention Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Paediatric Influenza Prevention in 2026
Figure 72. Manufacturing Process Analysis of Paediatric Influenza Prevention
Figure 73. Industry Chain Structure of Paediatric Influenza Prevention
Figure 74. Channels of Distribution
Figure 75. Global Paediatric Influenza Prevention Sales Market Forecast by Region (2027-2032)
Figure 76. Global Paediatric Influenza Prevention Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Paediatric Influenza Prevention Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Paediatric Influenza Prevention Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Paediatric Influenza Prevention Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Paediatric Influenza Prevention Revenue Market Share Forecast by Application (2027-2032)
